Acute Myeloid Leukemia: What to Know, What to Do
Learn what causes acute myeloid leukemia (AML), who's at risk of developing AML and treatment options.
Seminario web
You are here
Celebrating My Second Re-Birthday
A transplant survivor shares tips for preparing for transplant, making the hospitalization meaningful and surviving and thriving afterward.
¿Trasplante o terapia de células CAR T para el linfoma? Cómo decidir
Un trasplante que utiliza las propias células madre del paciente (trasplante autólogo de células madre) o la terapia de células CAR T son opciones de tratamiento para pacientes con ciertos tipos de linfoma.
Ser un Cuidador: Terapia de Células CAR T
Esta es la Transcripción del seminario web Ser un Cuidador: Terapia de células CAR T, que se emitió el 1 de febrero de 2023.
COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know
This is a recording of the webinar, COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know, that aired November 16, 2022.
Major Treatment Decisions for Patients with Acute Myeloid Leukemia (AML)
Acute myeloid leukemia is a diagnosis that affects mainly older adults. Treatment options depend on the type of AML a patient has, age, prior treatment and general health. Learn the details on how recommendations for treatment are determined.
Managing Vaginal Graft-versus-Host Disease (GVHD)
Graft-versus-host disease (GVHD) is a frequent complication after a stem cell transplant using donor cells. GVHD can affect many parts of the body including the genitals.
Prevención y Tratamiento de la Enfermedad Injerto Contra Huésped (EICH)
Prevention and Treatment of Graft-versus-Host Disease (GVHD) - Video in Spanish
CAR T-cells in Non-Hodgkin Lymphoma, A Hopeful Option
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
COVID-19: Precautions, Vaccines and Treatments for Transplant Recipients
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
Transplantation for Myelodysplastic Syndromes (MDS): Who, When and How
More than 60,000 people have myelodysplastic syndrome (MDS) in the U.S. Learn about the best treatment options.
Acute Myeloid Leukemia: Increasing Complexity and Increasing Treatment Opportunities
Learn about the different types of acute myeloid leukemia (AML), how it is treated, and when transplant is the best option.
Treatment Options for Sickle Cell Disease
Bone marrow transplants and gene therapy for sickle cell disease: treatment options to consider.
Managing Neuropathy after Transplant
Peripheral neuropathy is common after transplant. Learn the symptoms and effective treatment options.
CAR-T y Otras Inmunoterapias: Su Papel Después del Trasplante
¿Qué es la terapia con el receptor de antígeno quimérico (CAR-T)? ¿Quién es candidato para la terapia CAR-T?
Transplant Options for Patients with Hodgkin Disease
Understanding current and new treatment options
Donating Bone Marrow or Stem Cells to a Relative
A comprehensive explanation of what is involved in donating bone marrow or stem cells to a relative.
Stem Cell Transplants for Acute Myeloid Leukemia: What You Need to Know
A comprehensive discussion of who should consider a transplant for acute myeloid leukemia (AML) and when.
Family Caregivers 101: What to Expect When Caring for a Recovering Transplant Patient
An in-depth discussion about the family caregiver's role during and after transplant.
Transplants 101: An Introduction to Bone Marrow, Stem Cell and Cord Blood Transplants
An overview of bone marrow, peripheral blood stem cell and cord blood transplantation.
An Introduction to Chronic Graft-versus-Host-Disease (cGVHD)
Chronic GVHD is a common problem after a transplant using donor cells (allogeneic transplant).
Bone Marrow Transplant and Integrative Oncology
An overview of various complementary medical practices used by transplant patients, their safety and effectiveness.
